### [2020-12-12](/feed/2020/12/12/index.md)

##### COVID-19 pandemic
# Peru temporarily suspends Phase III trials of Sinopharm's vaccine after detecting neurological problems in one of its volunteers. Peru's trials for the vaccine were due to conclude this week, after testing around 12,000 people. 

Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in ...


### Sources:

1. [CNA](https://www.channelnewsasia.com/news/world/peru-suspends-clinical-trials-china-sinopharm-covid-19-vaccine-13757116) [Image](https://cna-sg-res.cloudinary.com/image/upload/q_auto,f_auto/image/13757114/16x9/991/557/f14aa68ea6f7366985bdc5e5c59d7d97/NH/peru-s-clinical-trials-for-the-vaccine-developed-by-chinese-drug-giant-sinopharm-were-due-to-conclude-this-week-after-testing-around-12000-people-1607755322370-2.jpg)

### Related:

1. [The National Agency for Food and Drug Administration and Control approves the Sinopharm BBIBP-CorV vaccine for emergency use in Nigeria. ](/feed/2021/08/24/the-national-agency-for-food-and-drug-administration-and-control-approves-the-sinopharm-bbibp-corv-vaccine-for-emergency.md) _Context: COVID-19 pandemic, Sinopharm_
2. [Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant. ](/feed/2021/08/12/cambodia-begins-to-administer-the-oxford-astrazeneca-covid-19-vaccine-as-a-third-booster-dose-to-people-who-have-recei.md) _Context: COVID-19 pandemic, Sinopharm_
3. [The Ministry of Health approves the emergency use of the Sinopharm BBIBP-CorV vaccine, making it the third vaccine to be authorized for use in the country. ](/feed/2021/06/4/the-ministry-of-health-approves-the-emergency-use-of-the-sinopharm-bbibp-corv-vaccine-making-it-the-third-vaccine-to-be.md) _Context: COVID-19 pandemic, Sinopharm_
4. [Peru reports a record 11,260 new confirmed cases of COVID-19 in the past 24 hours, thereby bringing the nationwide total of confirmed cases to 1,492,519. ](/feed/2021/03/25/peru-reports-a-record-11260-new-confirmed-cases-of-covid-19-in-the-past-24-hours-thereby-bringing-the-nationwide-total.md) _Context: COVID-19 pandemic, Peru_
5. [Venezuela receives 500,000 doses of the Sinopharm BBIBP-CorV vaccine donated by China. ](/feed/2021/03/2/venezuela-receives-500000-doses-of-the-sinopharm-bbibp-corv-vaccine-donated-by-china.md) _Context: COVID-19 pandemic, Sinopharm_
6. [Venezuela approves the emergency use of Sinopharm BBIBP-CorV vaccine. ](/feed/2021/03/1/venezuela-approves-the-emergency-use-of-sinopharm-bbibp-corv-vaccine.md) _Context: COVID-19 pandemic, Sinopharm_
7. [Cambodia launches a vaccination campaign against COVID-19 using 600,000 doses of Sinopharm's BBIBP-CorV vaccine. The son of Prime Minister Hun Sen, Hun Manet, and several cabinet ministers are among the first people to get vaccinated. ](/feed/2021/02/10/cambodia-launches-a-vaccination-campaign-against-covid-19-using-600000-doses-of-sinopharm-s-bbibp-corv-vaccine-the-son.md) _Context: COVID-19 pandemic, Sinopharm_
8. [Peru launches a vaccination program against COVID-19 two days after it received 300,000 doses of Sinopharm's BBIBP-CorV vaccine. President Francisco Sagasti becomes the first person to get vaccinated. ](/feed/2021/02/9/peru-launches-a-vaccination-program-against-covid-19-two-days-after-it-received-300000-doses-of-sinopharm-s-bbibp-corv.md) _Context: COVID-19 pandemic, Peru, Sinopharm_
9. [Sinopharm is setting up production lines to supply up to one billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials. Sinopharm is currently testing the vaccines in ten countries, including Egypt, Argentina, Jordan, and Peru. ](/feed/2020/10/20/sinopharm-is-setting-up-production-lines-to-supply-up-to-one-billion-doses-of-two-covid-19-vaccines-currently-being-test.md) _Context: COVID-19 pandemic, Peru, Sinopharm_
10. [Sinopharm began Phase III trials in Peru starting with two dozen people, with the goal to vaccinate 6,000 people between the ages of 18 and 75. So far, Sinopharm has given 30,000 doses to volunteers and another 10,000 participants have received double doses in Bahrain and the United Arab Emirates, with additional trials planned for Morocco and Argentina. ](/feed/2020/09/10/sinopharm-began-phase-iii-trials-in-peru-starting-with-two-dozen-people-with-the-goal-to-vaccinate-6000-people-between.md) _Context: COVID-19 pandemic, Peru, Sinopharm_